Mustang Bio Inc (MBIO)
0.2702
-0.02
(-5.56%)
USD |
NASDAQ |
May 09, 16:00
0.2702
0.00 (0.00%)
After-Hours: 16:33
Mustang Bio Net Income (Quarterly): -8.616M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -8.616M |
September 30, 2023 | -10.06M |
June 30, 2023 | -16.24M |
March 31, 2023 | -16.69M |
December 31, 2022 | -19.63M |
September 30, 2022 | -19.00M |
June 30, 2022 | -19.10M |
March 31, 2022 | -19.80M |
December 31, 2021 | -20.05M |
September 30, 2021 | -17.00M |
June 30, 2021 | -14.36M |
March 31, 2021 | -14.96M |
December 31, 2020 | -20.61M |
September 30, 2020 | -12.95M |
June 30, 2020 | -14.60M |
March 31, 2020 | -11.86M |
December 31, 2019 | -16.21M |
Date | Value |
---|---|
September 30, 2019 | -10.17M |
June 30, 2019 | -10.40M |
March 31, 2019 | -9.613M |
December 31, 2018 | -11.77M |
September 30, 2018 | -7.518M |
June 30, 2018 | -5.093M |
March 31, 2018 | -6.281M |
December 31, 2017 | -15.60M |
September 30, 2017 | -6.94M |
June 30, 2017 | -5.529M |
March 31, 2017 | -3.218M |
December 31, 2016 | -8.748M |
September 30, 2016 | -1.87M |
June 30, 2016 | -1.133M |
March 31, 2016 | -0.903M |
December 31, 2015 | -0.911M |
September 30, 2015 | -0.716M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-20.61M
Minimum
Dec 2020
-8.616M
Maximum
Dec 2023
-15.38M
Average
-16.21M
Median
Dec 2019
Net Income (Quarterly) Benchmarks
Fortress Biotech Inc | -9.279M |
Avinger Inc | -5.024M |
AIM ImmunoTech Inc | -12.58M |
Protalix BioTherapeutics Inc | -6.044M |
Armata Pharmaceuticals Inc | -19.85M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 8.856M |
EPS Diluted (Quarterly) | -0.71 |
Enterprise Value | -3.261M |
Earnings Yield | -2.22K% |